Creative Planning Dr Reddys Laboratories LTD Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Creative Planning holds 104,512 shares of RDY stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

104,512

Previous 87,522 19.41%

Holding current value

$1.48 Million

Previous $6.67 Million 24.52%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$75.41 - $84.21 $1.28 Million - $1.43 Million	16,990 Added 19.41%	104,512 $8.3 Million
Q2 2024 Aug 15, 2024	BUY	$68.26 - $76.19 $1.1 Million - $1.23 Million	16,157 Added 22.64%	87,522 $6.67 Million
Q1 2024 May 10, 2024	BUY	$67.36 - $77.59 $920,541 - $1.06 Million	13,666 Added 23.68%	71,365 $5.23 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $1.42 Million - $1.55 Million	22,105 Added 62.1%	57,699 $4.01 Million
Q3 2023 Nov 16, 2023	BUY	$61.9 - $72.77 $375,361 - $441,277	6,064 Added 20.54%	35,594 $2.38 Million
Q2 2023 Jul 21, 2023	BUY	$53.34 - $63.11 $443,042 - $524,191	8,306 Added 39.13%	29,530 $1.86 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $484,857 - $534,629	9,391 Added 79.36%	21,224 $1.21 Million
Q4 2022 Feb 10, 2023	BUY	$51.15 - $57.45 $85,676 - $96,228	1,675 Added 16.49%	11,833 $612,000
Q3 2022 Nov 03, 2022	BUY	$49.9 - $57.32 $325,697 - $374,127	6,527 Added 179.76%	10,158 $532,000
Q2 2022 Aug 15, 2022	BUY	$49.62 - $58.13 $180,170 - $211,070	3,631 New	3,631 $201,000
Q3 2021 Nov 10, 2021	SELL	$60.19 - $75.29 $273,864 - $342,569	-4,550 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$62.12 - $74.2 $458,880 - $548,115	-7,387 Reduced 61.88%	4,550 $334,000
Q1 2021 Apr 30, 2021	SELL	$57.98 - $73.08 $232,673 - $293,270	-4,013 Reduced 25.16%	11,937 $733,000
Q4 2020 Jan 29, 2021	BUY	$62.61 - $71.29 $692,654 - $788,681	11,063 Added 226.38%	15,950 $1.14 Million
Q3 2020 Nov 05, 2020	SELL	$51.39 - $72.41 $6,577 - $9,268	-128 Reduced 2.55%	4,887 $340,000
Q2 2020 Jul 23, 2020	SELL	$39.55 - $54.65 $11,865 - $16,395	-300 Reduced 5.64%	5,015 $266,000
Q1 2020 May 05, 2020	SELL	$34.75 - $45.85 $42,256 - $55,753	-1,216 Reduced 18.62%	5,315 $214,000
Q3 2019 Nov 01, 2019	BUY	$34.82 - $39.26 $7,103 - $8,009	204 Added 3.22%	6,531 $247,000
Q1 2019 Apr 24, 2019	BUY	$35.77 - $40.57 $10,909 - $12,373	305 Added 5.06%	6,327 $256,000
Q4 2018 Feb 01, 2019	BUY	$31.89 - $38.44 $5,899 - $7,111	185 Added 3.17%	6,022 $227,000
Q3 2018 Oct 25, 2018	SELL	$29.25 - $36.73 $49,140 - $61,706	-1,680 Reduced 22.35%	5,837 $202,000
Q1 2018 Apr 18, 2018	SELL	$31.93 - $39.54 $15,965 - $19,770	-500 Reduced 6.24%	7,517 $246,000
Q3 2017 Oct 17, 2017	BUY	$30.11 - $37.72 $241,391 - $302,401	8,017	8,017 $286,000

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.2M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.35B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Dr Reddys Laboratories LTD Transaction History